8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) March 19, 2009

ELECSYS CORPORATION

(Exact name of registrant as specified in its charter)

KANSAS	0-22760	48-1099142
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Identification Employer No.)

846 N. Mart-Way Court, Olathe, Kansas	66061
(Address of principal executive offices)	(Zip Code)

 Registrant’s telephone number, including area code (913) 647-0158

Not Applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 1.01                      Entry into a Material Definitive Agreement.

On March 19, 2009, Elecsys Corporation (the "Company") entered into a Stock Purchase Agreement (the "Agreement") to acquire MBBS, S.A. of Cortaillod, Switzerland ("MBSS") from BSN Systems, Inc. of Irvine California ("BSN").  Under the terms of the Agreement, the Company will acquire all of the capital stock of MBSS from BSN in exchange for 175,000 shares of the Company's common stock.  Additional performance related consideration may be earned over the next five years.  The acquisition is subject to certain closing conditions and is expected to close by June 16, 2009. A copy of the press release announcing the transaction is furnished under Item 1.01 of this Form 8-K as Exhibit 99.1.

Item 3.02                      Unregistered Sales of Equity Securities.

As described above, the Company is obligated pursuant to the terms of the Agreement to issue 175,000 shares of its common stock to BSN in exchange for all of the capital stock of MBSS.  The Company believes the transaction is exempt from the registration requirements of the Securities Act of 1933, as amended (the "Act") by reason of Section 4(2) of the Act on the grounds that the transaction did not involve a public offering.

Item 9.01                      Financial Statements and Exhibits.

(c)           EXHIBITS.  The following exhibits are filed herewith:

99.1           Press Release dated March 19, 2009.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant hasduly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ELECSYS CORPORATION
Date:  March 19, 2009	By:	/s/ Karl Gemperli
		Karl Gemperli
		Chief Executive Officer

EXHIBIT INDEX

Exhibit Number                  Description

          99.1                            Press release dated March 19, 2009.

EX-99.1

     NEWS RELEASE

846 N. Mart-Way Court, Olathe, Kansas 66061                                      Phone: 913-647-0158                             Fax:  913-647-0132

investorrelations@elecsyscorp.com

FOR IMMEDIATE RELEASE:
 

ELECSYS CORPORATION ANNOUNCES ITS ACQUISITION OF MBBS, S.A.

Olathe, Kansas (March 19, 2009) – Elecsys Corporation (NASDAQ: ESYS) announced today that it has entered into a Stock Purchase Agreement to acquire MBBS, S.A., of Cortaillod, Switzerland from BSN Systems, Inc. of Irvine, California.

MBBS, a Swiss high-technology company established in 2000, is a leader in the design and development of radio frequency identification (RFID) solutions for harsh and extreme environments.  Based on research and development originally funded by the Swiss government, MBBS’ patented METALuCID® RFID technology is characterized by its unique ability to read and write electronic data through metals such as non-magnetic steels and other alloys.  With this feature, RFID tags can be hermetically sealed inside metal parts such as surgical instruments, infrastructure assets, heavy equipment, weapons and similar devices that must withstand harsh environments.

MBBS offers complete RFID solutions, including custom tags, readers and software.  This ultra-rugged RFID technology is fully developed and traceability solutions deployed by MBBS have been used in various applications in the medical and industrial sectors for several years. MBBS’ revenues totaled approximately $550,000 for its most recent fiscal year ended December 31, 2008.  MBBS has been certified to ISO 9001 and ISO 13485 since 2004.

Karl Gemperli, Elecsys president and chief executive officer, stated, “We are excited about penetrating the expanding market for ultra-rugged RFID solutions.  The MBBS tags can resist high temperatures, pressures, chemicals and similar conditions where other tags would fail.  These capabilities are an ideal fit for the harsh environments found in our existing customer markets where a wide range of potential new applications for this technology exist.”

Gemperli continued, “Especially small in size, these tags can be inserted directly into parts and other devices to build a permanent and robust tracking system.  We believe that this technology, coupled with the market penetration and strength of our established ultra-rugged computer and remote monitoring brands, has the potential to greatly expand our business.”

Under the terms of the Agreement, Elecsys will acquire all of MBBS’ capital stock from BSN Systems in exchange for 175,000 shares of Elecsys Corporation common stock.  Additional performance related consideration may be earned over the next five years.  BSN Systems is an investment holding company whose major stockholders include Sandoz FF Holding, S.A. and Techniques d’Avant Garde (TAG) ID, S.A.  The acquisition is subject to certain closing conditions and Elecsys expects to close on this purchase by June 16, 2009.

About Elecsys Corporation

Elecsys Corporation tailors specific technology solutions for customers wherever high quality, reliability, and innovation are essential.  Elecsys provides electronic design and manufacturing services, custom liquid crystal displays (“LCDs”), ultra-rugged mobile computing devices and wireless remote monitoring solutions to numerous industries worldwide.  Markets served include energy infrastructure, aerospace, transportation, logistics, law enforcement, safety, military, medical and other critical industries.  Elecsys operates its business through three wholly-owned subsidiaries, DCI, Inc., Radix Corporation and NTG, Inc.  For more information, visit www.elecsyscorp.com.

 Safe-Harbor Statement<?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />

The discussions set forth in this press release may contain forward-looking comments based on current expectations that involve a number of risks and uncertainties. Actual results could differ materially from those projected or suggested in the forward-looking comments. The difference could be caused by a number of factors, including, but not limited to the factors and conditions that are described in Elecsys Corporation's SEC filings, including the Form 10-KSB for the year ended April 30, 2008. The reader is cautioned that Elecsys Corporation does not have a policy of updating or revising forward-looking statements and thus he or she should not assume that silence by management of Elecsys Corporation over time means that actual events are bearing out as estimated in such forward-looking statements.

#   #   #

Investor Relations Contact:        Todd A. Daniels

                                                       Elecsys Corporation

                                                       (913) 647-0158, Phone

          (913) 647-0132, Fax

     investorrelations@elecsyscorp.com

Media Inquiries Contact:            Shelley Bartkoski

                                                      Hagen and Partners

                                                      (913) 642-3715

                                                      sbartkoski@hagenandpartners.com